Monday, 13 Sep 2021 | Funding Deadline
The key aim of DEBRA International is to coordinate, in collaboration with its members, activities that are for the benefit of everyone affected by Epidermolysis bullosa (EB) globally: the international patient community, patient support and advocacy groups, healthcare professionals, researchers, and industry. Project topics should fit one or more of DEBRA's and EB-ResNet's four strategic research priorities: 1. Improving understanding of EB biology to create new concepts for diagnosis and treatment. 2. Developing disease-modifying and curative therapies. 3. Preventing and curing severe disease consequences: chronic wounds, fibrosis, and cancer. 4. Improving clinical care and symptom relief through research.
Deadline for proposals: 13 September 2021
Find out more here